Why Reconstituted Peptides Are Less Stable Tesamorelin, like many peptide therapeutics, consists of a chain of amino acids (44 in total)
Injectable Protocol (Systemic + Gut) For users who want systemic delivery alongside gut-targeted action: Loading Phase (Weeks 1 to 4): BPC-157: 250 to 500 mcg per day, subcutaneous injection (abdomen) KPV: 200 to 500 mcg per day, subcutaneous injection (abdomen) Maintenance Phase (Weeks 5 to 8): BPC-157: 250 mcg per day KPV: 200 to 300 mcg per day Extended Stack Options For enhanced regenerative effect beyond gut health, some practitioners add: TB-500: 2 to 2.5 mg twice weekly adds systemic cell migration and tissue remodeling for broader recovery GHK-Cu: 1 to 2 mg per day subcutaneous adds collagen production support and wound healing acceleration Timing and Administration Notes For oral gut-focused use, some users dose BPC-157 in the morning and KPV in the evening to maintain continuous coverage throughout the day
Bevilacqua, Arturo, and Mariano Bizzarri
Small fiber neuropathy Small fiber neuropathy (SFN) affects unmyelinated C-fibers and thinly myelinated A-delta fibers, producing burning pain, tingling, and autonomic symptoms
Simultaneously, the peptides interplay with the endogenous nitric oxide (NO) system acts as a master stabilizer 1
Free shipping on orders over $200